Last updated on February 2018

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers


Brief description of study

The clinical trial will assess the delivery of Nitric Oxide topically to the diabetic foot ulcer wound and the surrounding wound area as it related to wound healing.

The objective of the study is to assess the Nitric Oxide Therapy treatment time (the number of minutes to deliver the treatment) and frequency (number of days per week to treat) to determine the most optimal treatment time and frequency to develop a rationale for safety and efficacy for the final APT001 clinical study.

Detailed Study Description

APT001 is a medical device that generates nitric oxide (NO) from ambient room air within a defined plasma stream. This study is a randomized, prospective, multi-center feasibility study that will assess the effect of Nitric Oxide treatment time (minutes) and frequency (days/week) on wound healing in adults with diabetic foot ulcers (DFUs) and to provide information that will be used to develop final safety and effectiveness hypotheses for a pivotal trial of the APT001 device.

Clinical Study Identifier: NCT03078933

Find a site near you

Start Over

Clinical Site

Montgomery, AL United States
  Connect »

Clinical Site

Phoenix, AZ United States
  Connect »

Clinical Site

Tucson, AZ United States
  Connect »

Clinical Site

Fresno, CA United States
  Connect »

Clinical Site

Los Angeles, CA United States
  Connect »

Clinical Site

San Francisco, CA United States
  Connect »

Clinical Site

Sylmar, CA United States
  Connect »

Clinical Site

Cooper City, FL United States
  Connect »

Clinical Site

Miami, FL United States
  Connect »

Clinical Site

Boston, MA United States
  Connect »

Clinical Site

West Columbia, SC United States
  Connect »

Clinical Site

Corpus Christi, TX United States
  Connect »

Clinical Site

San Antonio, TX United States
  Connect »

Clinical Site

Webster, TX United States
  Connect »